Fréget Glaser & Associés assisted the Novartis laboratory in its appeal against the Competition Authority’s decision. The Roche laboratory was advised by Dechert LLP. Novartis has...
Novartis and Roche’s Appeal Against the French Competition Authority
Havea’s Acquisition of Biocyte
Dechert advised Havea. PwC Société d’Avocats carried out tax due diligence on behalf of Havea Group. Havea Group has announced that it has entered into exclusive negotiations...
Chiesi Farmaceutici’s Acquisition of Amryt Pharma Plc
Dechert advised Chiesi Farmaceutici S.p.A. Gide Loyrette Nouel represented BNP Paribas. Amryt Pharma was advised by Cooley. Italian pharmaceutical company Chiesi Farmaceutici has signed a definitive agreement to acquire Amryt Pharma in...
Mayoly Spindler’s Acquisition of Ipsen Consumer HealthCare
Deloitte | Taj et M&A Transaction Services and Dechert advised Mayoly Spindler, while Allen & Overy advised Ipsen. Weil Gotshal & Manges advised Caravelle and Capza...
Perrigo Company’s $2.1 Billion Acquisition of HRA Pharma
Wachtell, Lipton, Rosen & Katz and Darrois Villey Maillot Brochier advise Perrigo, while Latham & Watkins served as the selling shareholders’ legal counsel and Dechert, as...